FRMM earnings analysis
What we found in FRMM's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
Forum Markets reported Q2 revenue of $1.365 million, down from $3.0 million in Q1 2026 and well below the $3.22 million consensus estimate. Diluted EPS improved to negative $0.73 from negative $3.58, but still missed the negative $0.27 estimate. The filing provides no quantitative guidance and highlights ineffective disclosure controls as of June 30, 2026, alongside new risks related to acquisitions, strategic alternatives, and discretionary repurchases.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- Revenue declined sharply and missed estimates
- Q2 revenue was $1.365 million versus $3.0 million in Q1 2026, a sequential decline of approximately 54.5%; revenue also missed the $3.22 million consensus estimate by approximately 57.6%.
- EPS improved sequentially but missed consensus
- Diluted EPS was negative $0.73 versus negative $3.58 in Q1 2026, an improvement of $2.85 per share, but it missed the negative $0.27 consensus estimate by $0.46.
- Control remediation remains underway
- Management stated that disclosure controls were not effective as of June 30, 2026, and reiterated that internal control over financial reporting was not effective as of December 31, 2025.
- ERP and control enhancements implemented
- The company implemented a new NetSuite ERP system in the fourth quarter of 2025 and added automated systems intended to improve internal control over financial reporting.
- Share repurchase activity continued
- During Q2, the company repurchased 7,086,811 shares under its program; the amended program permits repurchases of up to $100.0 million and expires no later than June 30, 2027.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- Acquisition integration and funding risk
- The company identified acquisitions as a substantive changed risk. It disclosed that future acquisitions could be difficult to integrate and could increase expenses, disrupt ongoing operations, and divert management attention; the Q1 2026 analysis also referenced an approximately $12 million aircraft-engine acquisition.
- Strategic alternatives create execution risk
- The company added a substantive changed risk concerning strategic alternatives, including a potential acquisition, merger, sale, strategic partnership, capital raise, or distribution of capital and assets. The process could involve significant transaction costs, dilution, disruption, or a decline in the common-stock price.
- Repurchases may consume liquidity
- The company added a substantive changed risk for discretionary stock repurchases. Since August 22, 2025, it purchased 9,515,782 shares for $79.5 million at an average price of $8.45, while the program can be suspended or terminated based on liquidity and other factors.
- Material weakness in financial reporting controls
- Disclosure controls were determined to be ineffective as of June 30, 2026, and the previously identified material weakness relates to classification and technical accounting review of significant one-time transactions.
- Revenue volatility and estimate miss
- Q2 revenue of $1.365 million was approximately 54.5% below Q1 revenue of $3.0 million and approximately 57.6% below the $3.22 million consensus estimate, indicating substantial near-term operating volatility.
What they reported.
What the company itself reported, taken out of the document.
- Earnings per share
- $-0.73
What they said about what is next.
No quantitative revenue or EPS outlook was provided in the extracted 10-Q text; numeric fields left null.
The filing reads worse than the one before it.
What came before.
- 10-Q · May 15, 2026
- Forum Markets, Incorporated reported Q1 2026 results marked by a total revenue of $2.9 million, a significant increase from no revenue a year prior, driven by a strategic shift towards a digital asset-focused business…
- 10-K · April 1, 2026
- Forum Markets (FRMM) completed a strategic pivot in 2025–early 2026 from legacy pharma/iGaming to building an RWA tokenization platform supported by capital markets and blockchain infrastructure. Management raised…
- 10-Q · November 14, 2025
- Ethzilla (formerly 180 Life Sciences) reported first substantial quarter after a strategic pivot to digital asset staking. Revenue of $4,110,169 was generated (new staking revenue), but operating loss widened to…
- 10-Q · July 23, 2025
- 180 Life Sciences (FRMM) remains a pre-revenue company; it reported a net loss of $1,726,604 for the quarter and $4,095,836 for the six months ended June 30, 2025 and had $2,218,331 in cash at quarter end. Management is…
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing FRMM makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever